A Red‐Light‐Activated Ruthenium‐Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells
Open Access
- 9 August 2017
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 129 (38) , 11707-11711
Abstract
We describe two water‐soluble ruthenium complexes, [1]Cl2 and [2]Cl2, that photodissociate to release a cytotoxic nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with a low dose (21 J cm−2) of red light in an oxygen‐independent manner. Using a specific NAMPT activity assay, up to an 18‐fold increase in inhibition potency was measured upon red‐light activation of [2]Cl2, while [1]Cl2 was thermally unstable. For the first time, the dark and red‐light‐induced cytotoxicity of these photocaged compounds could be tested under hypoxia (1 % O2). In skin (A431) and lung (A549) cancer cells, a 3‐ to 4‐fold increase in cytotoxicity was found upon red‐light irradiation for [2]Cl2, whether the cells were cultured and irradiated with 1 % or 21 % O2. These results demonstrate the potential of photoactivated chemotherapy for hypoxic cancer cells, in which classical photodynamic therapy, which relies on oxygen activation, is poorly efficient.Keywords
Funding Information
- H2020 European Research Council (Starting Grant)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VIDI grant)
This publication has 44 references indexed in Scilit:
- Spontaneous Formation in the Dark, and Visible Light-Induced Cleavage, of a Ru–S Bond in Water: A Thermodynamic and Kinetic StudyInorganic Chemistry, 2013
- Potential photoactivated metallopharmaceuticals: from active molecules to supported drugsChemical Communications, 2010
- Photoactivated Biological Activity of Transition‐Metal ComplexesEuropean Journal of Inorganic Chemistry, 2010
- Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicineDalton Transactions, 2009
- Photorelease of GABA with visible light using an inorganic caging groupFrontiers in Neural Circuits, 2008
- A New Inorganic Photolabile Protecting Group for Highly Efficient Visible Light GABA UncagingChemBioChem, 2007
- Development of a Cy3‐Labeled Glucose Bioprobe and Its Application in Bioimaging and Screening for Anticancer AgentsAngewandte Chemie, 2007
- Sulforhodamine B colorimetric assay for cytotoxicity screeningNature Protocols, 2006
- Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agentsNature Structural & Molecular Biology, 2006
- Photodynamic therapy for cancerNature Reviews Cancer, 2003